Skip to content
Riskpilot
← Back to search
Sign in
Get full access
KK Therapeutics ApS
APS
Dissolved
Advertising protection
CVR 40378111
Amagerbrogade 18, 2300
København S
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2019 · 7 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
KK Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2019
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2019
Income statement
DKK thousands
Item
2019
Gross profit
-30
Staff expenses
-0
EBITDA
-30
Depreciation & amort.
-0
EBIT
-30
Net financials
-3
Profit before tax
-33
Tax
-0
Net profit
-33
Balance sheet
DKK thousands
Item
2019
Total assets
23
Equity
17
Long-term debt
0
Short-term debt
6
Total debt
6
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-3000000.0%
This company
2019
2019
Equity ratio
73.4%
This company
38.2%
Market median
+92% vs market
2019
2019
Return on equity
-190.5%
This company
18.4%
Market median
-1135% vs market
2019
2019
Net profit margin (of gross profit)
-3279000.0%
This company
2019
2019
Asset turnover (of gross profit)
-1.28×
This company
2019
2019
Debt / equity
0.36×
This company
0.62×
Market median
+42% vs market
2019
2019
Annual reports & filings
Annual report 2019
Filed via CVR / Virk · Period 2019-03-21 – 2019-12-31
View
PDF
More on KK Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
